Sunshine Biopharma (SBFM) Financials: Revenue & Earnings

SBFM price $2.96 +0.00 +0.15%

Ticker
SBFM
Price
$2.96
Change
+0.00 +0.15%
Market cap ?
$6.30M
P/E ?
-0.01
Dividend yield ?
0.00%
Beta ?
1.35
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Financials

2016201720182019202020212022202320242025
0044720021121714102284264345603240927873487428336305891

Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, lung, brain, prostate…

Fair value

SBFM fair value Not meaningful. Price $2.96.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare SBFM

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-3.40—9.60M
2026-08-13-23.00-24.009.30M8.70M
2026-05-13-2.50-1.608.09M9.20M
2026-04-03-3.00-2.708.60M10.00M
2025-11-13-1.90-1.309.42M11.10M
2025-08-12-3.90-1.109.41M11.20M
2025-05-15-4.40—8.90M—
2025-03-31-10.100.109.59M12.50M
2024-11-05-9.40-5,350.008.44M11.80M
2024-08-19-1,988.00-148.009.30M9.00M
2024-05-20-400.00-3,200.007.54M7.00M
2024-03-28-1,000.00-1,200.007.68M6.10M
2023-11-13-800.00-2,400.005.96M6.00M
2023-08-11-400.00-3,200.005.56M5.00M
2023-05-10-1,600.00—4.89M—
2023-04-04-30,000.00—3.94M—
2022-11-07-1,600.00—132.81K—
2022-08-03-600.00—150.31K—
2022-05-06-92,000.00—122.64K—
2022-03-21130.00—85.12K—
2021-11-09-636,000.00—50.38K—
2021-08-09-484,000.00—52.87K—
2021-05-11-1,128,000.00—40.06K—
2021-03-30-1,286.00—28.01K—
2020-11-11-183,600.00—17.15K—
2020-08-19-269,272.00—15.14K—
2020-05-18-126,522.00—11.10K—
2019-11-13-1,843,374.00—7.33K—
2019-08-15-1,430.00—3.03K—
2019-05-20-3,682,582.00—206—
2019-04-12-790.00—111.84K—
2018-11-16-3,630.00———
2018-08-17-2,576.00———
2018-05-21-1,128.00—91.17K—
2018-04-02-920.00———
2017-11-15-5,904,440.00———
2017-08-11-19,417,760.00———
2017-05-12-7,828,080.00———
2017-04-17-5,584.00———
2016-11-14-105,708,000.00———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-07NATAN DAVIDBuy58.30K——
2026-04-14NATAN DAVIDBuy100.00K——
2025-01-13Roy MichelOther0——
2024-03-04Slilaty Steve N.Buy100.00K$0.1010.00K
2024-02-08Slilaty Steve N.Buy20.00K$0.102.00K
2024-01-26Beaudoin MarcOther0——
2022-11-30Sebaaly CamilleBuy30.00K$0.7622.91K
2022-10-20Chamoun MalekSell0——
2022-06-03Sebaaly CamilleBuy25.00K$1.2230.50K
2022-02-18Slilaty Steve N.Sell990.00K$0.1099.00K
2022-02-10NATAN DAVIDSell0——
2022-02-10Keller Andrew MarkSell0——
2021-10-31Kiderchah RabiSell0——
2021-10-31Kish James DanielSell0——
2021-10-31Kish James DanielOther0——
2021-10-31TELSEY ANDREW ISell0——
2021-01-06MERZOUKI ABDERRAZZAKBuy20.00M$0.0020.00K
2021-01-06Slilaty Steve N.Buy20.00M$0.0020.00K
2021-01-06Sebaaly CamilleBuy20.00M$0.0020.00K
2020-06-17Slilaty Steve N.Buy500.00K$0.1050.00K
2019-12-31Sebaaly CamilleSell323.67K$0.00324
2019-12-31Slilaty Steve N.Buy323.67K$0.00324
2019-12-19Sebaaly CamilleBuy1.30M$0.001.30K
2019-12-19MERZOUKI ABDERRAZZAKBuy1.30M$0.001.30K
2019-12-19Slilaty Steve N.Buy1.30M$0.001.30K
2019-10-20Sebaaly CamilleBuy1.10M$0.001.10K
2019-10-20MERZOUKI ABDERRAZZAKBuy1.10M$0.001.10K
2019-10-20Slilaty Steve N.Buy1.10M$0.001.10K
2019-09-11Sebaaly CamilleBuy550.00K$0.00550
2019-09-11Sebaaly CamilleBuy11.00M$0.0011.00K
2019-09-02MERZOUKI ABDERRAZZAKBuy13.00M$0.0013.00K
2019-09-02Sebaaly CamilleBuy13.00M$0.0013.00K
2019-09-02Slilaty Steve N.Buy13.00M$0.0013.00K
2018-08-27MERZOUKI ABDERRAZZAKBuy38.00M$0.0038.00K
2018-08-27MERZOUKI ABDERRAZZAKBuy38.00M$0.0038.00K
2018-08-27Sebaaly CamilleBuy38.00M$0.0038.00K
2018-08-27Slilaty Steve N.Buy38.00M$0.0038.00K
2018-06-20MERZOUKI ABDERRAZZAKBuy27.00M$0.0027.00K
2018-06-20MERZOUKI ABDERRAZZAKBuy27.00M$0.0027.00K
2018-06-20Sebaaly CamilleBuy27.00M$0.0027.00K
2018-06-20Slilaty Steve N.Buy27.00M$0.0027.00K
2018-04-22MERZOUKI ABDERRAZZAKBuy12.00M$0.0012.00K
2017-07-20MERZOUKI ABDERRAZZAKBuy14.00M$0.0014.00K
2017-07-20MERZOUKI ABDERRAZZAKBuy14.00M$0.0014.00K
2017-07-20Sebaaly CamilleBuy14.00M$0.0014.00K
2017-07-20Slilaty Steve N.Buy14.00M$0.0014.00K
2016-12-06MERZOUKI ABDERRAZZAKBuy28.00M$0.0028.00K
2016-12-06MERZOUKI ABDERRAZZAKBuy26.00M$0.0026.00K
2016-12-06Sebaaly CamilleBuy26.00M$0.0026.00K
2016-12-06Slilaty Steve N.Buy26.00M$0.0026.00K
2016-10-10Advanomics CorpSell136.86M——
2016-10-10Sebaaly CamilleBuy129.47M——
2016-10-10Slilaty Steve N.Sell136.86M——
2016-07-08Advanomics CorpSell0——
2016-07-08Slilaty Steve N.Buy321.31M$0.00835.39K
2016-04-22Slilaty Steve N.Buy12.00M$0.0184.00K
2016-04-22Sebaaly CamilleBuy12.00M$0.0184.00K
2016-04-22MERZOUKI ABDERRAZZAKBuy12.00M$0.0184.00K
2016-04-12Slilaty Steve N.Buy253.08K$0.2050.01K
2015-05-27Slilaty Steve N.Buy500.00K$0.1050.00K
2015-02-20MERZOUKI ABDERRAZZAKOther0——
2015-02-20MERZOUKI ABDERRAZZAKOther0——
2015-02-20MERZOUKI ABDERRAZZAKSell0——
2015-02-20Di Turi MicheleOther0——
2015-01-09Slilaty Steve N.Sell1.20M$0.0224.00K
2015-01-09Slilaty Steve N.Buy150.00K$0.023.00K
2012-09-04Slilaty Steve N.Sell2.59M$0.05129.57K
2012-09-04Slilaty Steve N.Sell2.59M$0.05129.57K
2011-12-21Slilaty Steve N.Buy17.00M——
2011-12-21Slilaty Steve N.Sell17.00M——
2011-12-21Slilaty Steve N.Buy17.00M——
2011-12-21Slilaty Steve N.Sell17.00M——
2009-10-15Di Turi MicheleSell0——
2009-10-15Sebaaly CamilleSell0——
2009-10-15Slilaty Steve N.Other0——
2009-10-15Slilaty Steve N.Sell0——
2009-10-15Slilaty Steve N.Other17.00M——

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Earnings and financials

Sunshine Biopharma, Inc. (SBFM) trades at $2.96, with a market cap of $6.30M and a trailing P/E of -0.01. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
0044720021121714102284264345603240927873487428336305891

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Sunshine Biopharma (SBFM) Financials: Revenue & Earnings

SBFM$2.96+0.00 +0.15%

$6.30M

Market Cap

-0.01

P/E

—

Forward P/E

—

Score

Price History